The isoprenoid perillyl alcohol inhibits telomerase activity in prostate cancer cells

Biochimie

Volumn 94, Issue 12, 2012, Pages 2639-2648

  Sundin, Tabetha ^a   Peffley, Dennis M ^a   Gauthier, David ^a   Hentosh, Patricia ^a  

^a OLD DOMINION UNIVERSITY   (United States)

Author keywords

hTERT; mTOR; Perillyl alcohol; Rapamycin; Telomerase

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; MESSENGER RNA; PERILLYL ALCOHOL; RAPAMYCIN; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROSTATE CANCER; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TUMOR; CYSTEINE PROTEINASE INHIBITORS; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUPEPTINS; MALE; MONOTERPENES; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIROLIMUS; TELOMERASE; TOR SERINE-THREONINE KINASES;

EID: 84868194994     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2012.07.028     Document Type: Article

References (99)

1. C.E. Elson, D.M. Peffley, P. Hentosh, and H. Mo Isoprenoid-mediated inhibition of mevalonate synthesis: potential application to cancer Proc. Soc. Exp. Biol. Med. 221 1999 294 311
2. E. Gonzalez-Suarez, E. Samper, A. Ramirez, J.M. Flores, J. Martin-Caballero, J.L. Jorcano, and M.A. Blasco Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes EMBO J. 20 2001 2619 2630 (Pubitemid 32938547)
3. F.H. Sarkar, and Y. Li Cell signaling pathways altered by natural chemopreventive agents Mutat. Res. 555 2004 53 64 (Pubitemid 39345397)
4. H. Yang, and Q.P. Dou Targeting apoptosis pathway with natural terpenoids: implications for treatment of breast and prostate cancer Curr. Drug Targets 11 2010 733 744
5. J. Kirby, and J.D. Keasling Biosynthesis of plant isoprenoids: perspectives for microbial engineering Annu. Rev. Plant Biol. 60 2009 335 355
6. L. He, H. Mo, S. Hadisusilo, A.A. Qureshi, and C.E. Elson Isoprenoids suppress the growth of murine B16 melanomas in vitro and in vivo J. Nutr. 127 1997 668 674 (Pubitemid 27200738)
7. T. Jahangir, and S. Sultana Perillyl alcohol protects against Fe-NTA-induced nephrotoxicity and early tumor promotional events in rat experimental model Evid. Based Complement. Altern. Med. 4 2007 439 445
8. B.W. Liston, R. Nines, P.S. Carlton, A. Gupta, R. Aziz, W. Frankel, and G.D. Stoner Perillyl alcohol as a chemopreventive agent in N- nitrosomethylbenzylamine-induced rat esophageal tumorigenesis Cancer Res. 63 2003 2399 2403 (Pubitemid 36605175)
9. M.H. Pan, and C.T. Ho Chemopreventive effects of natural dietary compounds on cancer development Chem. Soc. Rev. 37 2008 2558 2574
10. T. Rabi, and A. Bishayee Terpenoids and breast cancer chemoprevention Breast Cancer Res. Treat. 115 2009 223 239
11. S.C. Chaudhary, M.S. Alam, M.S. Siddiqui, and M. Athar Perillyl alcohol attenuates Ras-ERK signaling to inhibit murine skin inflammation and tumorigenesis Chem. Biol. Interact. 179 2009 145 153
12. I.V. Lebedeva, Z.Z. Su, N. Vozhilla, L. Chatman, D. Sarkar, P. Dent, M. Athar, and P.B. Fisher Chemoprevention by perillyl alcohol coupled with viral gene therapy reduces pancreatic cancer pathogenesis Mol. Cancer Ther. 7 2008 2042 2050
13. H. Mo, and C.E. Elson Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention Exp. Biol. Med. (Maywood) 229 2004 567 585 (Pubitemid 38878903)
14. D.M. Peffley, C. Sharma, P. Hentosh, and R.D. Buechler Perillyl alcohol and genistein differentially regulate PKB/Akt and 4E-BP1 phosphorylation as well as eIF4E/eIF4G interactions in human tumor cells Arch. Biochem. Biophys. 465 2007 266 273 (Pubitemid 47283997)
15. C.G. Proud mTOR signalling in health and disease Biochem. Soc. Trans. 39 2011 431 436
16. B. Magnuson, B. Ekim, and D.C. Fingar Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks Biochem. J. 441 2012 1 21
17. S. Chan Targeting the mammalian target of rapamycin (mTOR): a new approach to treating cancer Br. J. Cancer 91 2004 1420 1424 (Pubitemid 39486341)
18. S. Carnesecchi, A. Bradaia, B. Fischer, D. Coelho, M. Scholler-Guinard, F. Gosse, and F. Raul Perturbation by geraniol of cell membrane permeability and signal transduction pathways in human colon cancer cells J. Pharmacol. Exp. Ther. 303 2002 711 715 (Pubitemid 35231245)
19. W. Zhu, T. Masaki, A.K. Cheung, and S.E. Kern In-vitro release of rapamycin from a thermosensitive polymer for the inhibition of vascular smooth muscle cell proliferation J. Bioequiv. Availab. 1 2009 3 12
20. A. Nokhodchi, K. Sharabiani, M.R. Rashidi, and T. Ghafourian The effect of terpene concentrations on the skin penetration of diclofenac sodium Int. J. Pharm. 335 2007 97 105 (Pubitemid 46482867)
21. A.K. Jain, N.S. Thomas, and R. Panchagnula Transdermal drug delivery of imipramine hydrochloride. I. Effect of terpenes J. Control Release 79 2002 93 101 (Pubitemid 34168193)
22. R.D. Buechler, and D.M. Peffley Proto oncogene/eukaryotic translation initiation factor (eIF) 4E attenuates mevalonate-mediated regulation of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase synthesis Mol. Carcinog. 41 2004 39 53 (Pubitemid 39195599)
23. K. Kawauchi, K. Ihjima, and O. Yamada IL-2 Increases human telomerase reverse transcriptase activity transcriptionally and posttranslationally through phosphatidylinositol 3′-kinase/Akt, heat shock protein 90, and mammalian target of rapamycin in transformed NK cells J. Immunol. 174 2005 5261 5269 (Pubitemid 40593164)
24. A. Jimeno, M.A. Rudek, P. Kulesza, W.W. Ma, J. Wheelhouse, A. Howard, Y. Khan, M. Zhao, H. Jacene, W.A. Messersmith, D. Laheru, R.C. Donehower, E. Garrett-Mayer, S.D. Baker, and M. Hidalgo Pharmacodynamic-guided modified continuous reassessment method-based, dose-finding study of rapamycin in adult patients with solid tumors J. Clin. Oncol. 26 2008 4172 4179
25. S. Morgan-Meadows, S. Dubey, M. Gould, K. Tutsch, R. Marnocha, R. Arzoomanin, D. Alberti, K. Binger, C. Feierabend, J. Volkman, S. Ellingen, S. Black, M. Pomplun, G. Wilding, and H. Bailey Phase I trial of perillyl alcohol administered four times daily continuously Cancer Chemother. Pharmacol. 52 2003 361 366 (Pubitemid 37363607)
26. P. Brousset, T. al Saati, N. Chaouche, R.C. Zenou, D. Schlaifer, S. Chittal, and G. Delsol Telomerase activity in reactive and neoplastic lymphoid tissues: infrequent detection of activity in Hodgkin's disease Blood 89 1997 26 31 (Pubitemid 26428174)
27. B. Fu, J. Quintero, and C.C. Baker Keratinocyte growth conditions modulate telomerase expression, senescence, and immortalization by human papillomavirus type 16 E6 and E7 oncogenes Cancer Res. 63 2003 7815 7824 (Pubitemid 37466714)
28. M. Hou, D. Xu, M. Bjorkholm, and A. Gruber Real-time quantitative telomeric repeat amplification protocol assay for the detection of telomerase activity Clin. Chem. 47 2001 519 524 (Pubitemid 32222468)
29. A. Karystinou, F. Dell'Accio, T.B. Kurth, H. Wackerhage, I.M. Khan, C.W. Archer, E.A. Jones, T.A. Mitsiadis, and C. De Bari Distinct mesenchymal progenitor cell subsets in the adult human synovium Rheumatology (Oxford) 48 2009 1057 1064
30. N.W. Kim, and F. Wu Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP) Nucleic Acids Res. 25 1997 2595 2597 (Pubitemid 27298154)
31. G. Dikmen, E. Dikmen, M. Kara, E. Sahin, P. Dogan, and N. Ozdemir Diagnostic implications of telomerase activity in pleural effusions Eur. Respir. J. 22 2003 422 426 (Pubitemid 37098922)
32. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method Methods 25 2001 402 408 (Pubitemid 34164012)
33. J.B. Han, Z.Z. Tao, S.M. Chen, Y.G. Kong, and B.K. Xiao Adenovirus-mediated transfer of tris-shRNAs induced apoptosis of nasopharyngeal carcinoma cell in vitro and in vivo Cancer Lett. 309 2011 162 169
34. C. Janson, L. Romanova, E. Hansen, A. Hubel, and C. Lam Immortalization and functional characterization of rat arachnoid cell lines Neuroscience 177 2011 23 34
35. A. Kar, D. Saha, G. Purohit, A. Singh, P. Kumar, V.K. Yadav, R.K. Thakur, and S. Chowdhury Metastases suppressor NME2 associates with telomere ends and telomerase and reduces telomerase activity within cells Nucleic Acids Res. 40 2012 2554 2565
36. N.W. Kim, M.A. Piatyszek, K.R. Prowse, C.B. Harley, M.D. West, P.L. Ho, G.M. Coviello, W.E. Wright, S.L. Weinrich, and J.W. Shay Specific association of human telomerase activity with immortal cells and cancer Science 266 1994 2011 2015
37. C.O. Marian, W.E. Wright, and J.W. Shay The effects of telomerase inhibition on prostate tumor-initiating cells Intl. J. Cancer 127 2010 321 331
38. H. Hosoi, M.B. Dilling, L.N. Liu, M.K. Danks, T. Shikata, A. Sekulic, R.T. Abraham, J.C. Lawrence Jr., and P.J. Houghton Studies on the mechanism of resistance to rapamycin in human cancer cells Mol. Pharmacol. 54 1998 815 824 (Pubitemid 28523173)
39. T. Kanaya, S. Kyo, M. Takakura, H. Ito, M. Namiki, and M. Inoue hTERT is a critical determinant of telomerase activity in renal-cell carcinoma Int. J. Cancer 78 1998 539 543 (Pubitemid 28507174)
40. G.A. Ulaner, J.F. Hu, T.H. Vu, L.C. Giudice, and A.R. Hoffman Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts Cancer Res. 58 1998 4168 4172 (Pubitemid 28440575)
41. Y.M. Zhao, Q. Zhou, Y. Xu, X.Y. Lai, and H. Huang Antiproliferative effect of rapamycin on human T-cell leukemia cell line Jurkat by cell cycle arrest and telomerase inhibition Acta Pharmacol. Sin. 29 2008 481 488 (Pubitemid 351465508)
42. C. Zhou, P.A. Gehrig, Y.E. Whang, and J.F. Boggess Rapamycin inhibits telomerase activity by decreasing the hTERT mRNA level in endometrial cancer cells Mol. Cancer Ther. 2 2003 789 795
43. H. Ouchi, H. Ishiguro, N. Ikeda, M. Hori, Y. Kubota, and H. Uemura Genistein induces cell growth inhibition in prostate cancer through the suppression of telomerase activity Int. J. Urol. 12 2005 73 80 (Pubitemid 40333005)
44. T.M. Nakamura, G.B. Morin, K.B. Chapman, S.L. Weinrich, W.H. Andrews, J. Lingner, C.B. Harley, and T.R. Cech Telomerase catalytic subunit homologs from fission yeast and human Science 277 1997 955 959 (Pubitemid 27366681)
45. K. Liu, R.J. Hodes, and N. Weng Cutting edge: telomerase activation in human T lymphocytes does not require increase in telomerase reverse transcriptase (hTERT) protein but is associated with hTERT phosphorylation and nuclear translocation J. Immunol. 166 2001 4826 4830 (Pubitemid 32280689)
46. S.S. Kang, T. Kwon, D.Y. Kwon, and S.I. Do Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit J. Biol. Chem. 274 1999 13085 13090
47. J.T. Chang, Y.C. Lu, Y.J. Chen, C.P. Tseng, Y.L. Chen, C.W. Fang, and A.J. Cheng hTERT phosphorylation by PKC is essential for telomerase holoprotein integrity and enzyme activity in head neck cancer cells Br. J. Cancer 94 2006 870 878
48. Y.W. Kim, S.Y. Hur, T.E. Kim, J.M. Lee, S.E. Namkoong, I.K. Ki, and J.W. Kim Protein kinase C modulates telomerase activity in human cervical cancer cells Exp. Mol. Med. 33 2001 156 163 (Pubitemid 32954693)
49. Y. Li, L. Liu, L.G. Andrews, and T.O. Tollefsbol Genistein depletes telomerase activity through cross-talk between genetic and epigenetic mechanisms Int. J. Cancer 125 2009 286 296
50. J. Haendeler, J. Hoffmann, R.P. Brandes, A.M. Zeiher, and S. Dimmeler Hydrogen peroxide triggers nuclear export of telomerase reverse transcriptase via Src kinase family-dependent phosphorylation of tyrosine 707 Mol. Cell. Biol. 23 2003 4598 4610 (Pubitemid 36734749)
51. S. Jakob, P. Schroeder, M. Lukosz, N. Buchner, I. Spyridopoulos, J. Altschmied, and J. Haendeler Nuclear protein tyrosine phosphatase Shp-2 is one important negative regulator of nuclear export of telomerase reverse transcriptase J. Biol. Chem. 283 2008 33155 33161
52. M. Meyerson, C.M. Counter, E.N. Eaton, L.W. Ellisen, P. Steiner, S.D. Caddle, L. Ziaugra, R.L. Beijersbergen, M.J. Davidoff, Q. Liu, S. Bacchetti, D.A. Haber, and R.A. Weinberg hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization Cell 90 1997 785 795 (Pubitemid 27357969)
53. J.W. Shay, and W.E. Wright Role of telomeres and telomerase in cancer Semin. Cancer Biol. 21 2011 349 353
54. C.K. Dong, K. Masutomi, and W.C. Hahn Telomerase: regulation, function and transformation Crit. Rev. Oncol. Hematol. 54 2005 85 93 (Pubitemid 40552830)
55. A.E. Bilsland, S. Hoare, K. Stevenson, J. Plumb, N. Gomez-Roman, C. Cairney, S. Burns, K. Lafferty-Whyte, J. Roffey, T. Hammonds, and W.N. Keith Dynamic telomerase gene suppression via network effects of GSK3 inhibition PLoS One 4 2009 e6459
56. T. Sundin, and P. Hentosh InTERTesting association among telomerase, mTOR, and phytochemicals Exp. Rev. Mol. Med. 14 2012 e8
57. S. Jagadeesh, S. Kyo, and P.P. Banerjee Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells Cancer Res. 66 2006 2107 2115
58. P. Thelen, J.G. Scharf, P. Burfeind, B. Hemmerlein, W. Wuttke, B. Spengler, V. Christoffel, R.H. Ringert, and D. Seidlova-Wuttke Tectorigenin and other phytochemicals extracted from leopard lily Belamcanda chinensis affect new and established targets for therapies in prostate cancer Carcinogenesis 26 2005 1360 1367 (Pubitemid 41417878)
59. X. Wang, M.W. Hao, K. Dong, F. Lin, J.H. Ren, and H.Z. Zhang Apoptosis induction effects of EGCG in laryngeal squamous cell carcinoma cells through telomerase repression Arch. Pharm. Res. 32 2009 1263 1269
60. J.H. Lee, and I.K. Chung Curcumin inhibits nuclear localization of telomerase by dissociating the Hsp90 co-chaperone p23 from hTERT Cancer Lett. 290 2010 76 86
61. D.M. Peffley, and A.K. Gayen Plant-derived monoterpenes suppress hamster kidney cell 3-hydroxy-3-methylglutaryl coenzyme a reductase synthesis at the post-transcriptional level J. Nutr. 133 2003 38 44 (Pubitemid 36070574)
62. H.H. Bailey, S. Attia, R.R. Love, T. Fass, R. Chappell, K. Tutsch, L. Harris, A. Jumonville, R. Hansen, G.R. Shapiro, and J.A. Stewart Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancer Cancer Chemother. Pharmacol. 62 2008 149 157 (Pubitemid 351537855)
63. R. Ram, O. Uziel, O. Eldan, E. Fenig, E. Beery, S. Lichtenberg, Y. Nordenberg, and M. Lahav Ionizing radiation up-regulates telomerase activity in cancer cell lines by post-translational mechanism via ras/phosphatidylinositol 3-kinase/Akt pathway Clin. Cancer Res. 15 2009 914 923
64. P. Hentosh, and D.M. Peffley The cladribine conundrum: deciphering the drug's mechanism of action Expert Opin. Drug Metab. Toxicol. 6 2010 75 81
65. E.P. Moiseeva, and M.M. Manson Dietary chemopreventive phytochemicals: too little or too much? Cancer Prev. Res. (Phila) 2 2009 611 616
66. J.H. Kim, S.M. Park, M.R. Kang, S.Y. Oh, T.H. Lee, M.T. Muller, and I.K. Chung Ubiquitin ligase MKRN1 modulates telomere length homeostasis through a proteolysis of hTERT Genes Dev. 19 2005 776 781
67. J. Salvatico, J.H. Kim, I.K. Chung, and M.T. Muller Differentiation linked regulation of telomerase activity by Makorin-1 Mol. Cell. Biochem. 342 2010 241 250
68. H. Seimiya, H. Sawada, Y. Muramatsu, M. Shimizu, K. Ohko, K. Yamane, and T. Tsuruo Involvement of 14-3-3 proteins in nuclear localization of telomerase EMBO J. 19 2000 2652 2661 (Pubitemid 30323553)
69. D. Peffley, and P. Hentosh Plant-derived isoprenoids mediate regulation of mTOR signaling in tumor cells M. Diederich, Natural Compounds as Inducers of Cell Death 2012 Springer Publishing
70. B.E. Jady, P. Richard, E. Bertrand, and T. Kiss Cell cycle-dependent recruitment of telomerase RNA and Cajal bodies to human telomeres Mol. Biol. Cell 17 2006 944 954 (Pubitemid 43191126)
71. R.L. Tomlinson, T.D. Ziegler, T. Supakorndej, R.M. Terns, and M.P. Terns Cell cycle-regulated trafficking of human telomerase to telomeres Mol. Biol. Cell 17 2006 955 965 (Pubitemid 43191127)
72. L. Yeruva, K.J. Pierre, A. Elegbede, R.C. Wang, and S.W. Carper Perillyl alcohol and perillic acid induced cell cycle arrest and apoptosis in non small cell lung cancer cells Cancer Lett. 257 2007 216 226 (Pubitemid 47538829)
73. J. Li, L. Xue, H. Hao, Y. Han, J. Yang, and J. Luo Rapamycin provides a therapeutic option through inhibition of mTOR signaling in chronic myelogenous leukemia Oncol. Rep. 27 2012 461 466
74. S.D. Perrault, P.J. Hornsby, and D.H. Betts Global gene expression response to telomerase in bovine adrenocortical cells Biochem. Biophys. Res. Commun. 335 2005 925 936 (Pubitemid 41188284)
75. W. Liang, D. Ye, L. Dai, Y. Shen, and J. Xu Overexpression of hTERT extends replicative capacity of human nucleus pulposus cells, and protects against serum starvation-induced apoptosis and cell cycle arrest J. Cell. Biochem. 2012
76. R. Rahman, L. Latonen, and K.G. Wiman hTERT antagonizes p53-induced apoptosis independently of telomerase activity Oncogene 24 2005 1320 1327 (Pubitemid 40343112)
77. X. Wu, B. Song, J. Zhang, L. Li, H. Ji, G. Lu, Z. Chen, W. Li, and Z. Zhou Human telomerase reverse transcriptase transfection reduces apoptosis in human penile smooth muscle cells and slows down cellular aging J. Sex. Med. 9 2012 494 504
78. D. Del Bufalo, A. Rizzo, D. Trisciuoglio, G. Cardinali, M.R. Torrisi, U. Zangemeister-Wittke, G. Zupi, and A. Biroccio Involvement of hTERT in apoptosis induced by interference with Bcl-2 expression and function Cell. Death Differ. 12 2005 1429 1438 (Pubitemid 41521933)
79. C. Dudognon, F. Pendino, J. Hillion, A. Saumet, M. Lanotte, and E. Segal-Bendirdjian Death receptor signaling regulatory function for telomerase: hTERT abolishes TRAIL-induced apoptosis, independently of telomere maintenance Oncogene 23 2004 7469 7474 (Pubitemid 39389688)
80. C. Massard, Y. Zermati, A.L. Pauleau, N. Larochette, D. Metivier, L. Sabatier, G. Kroemer, and J.C. Soria hTERT: a novel endogenous inhibitor of the mitochondrial cell death pathway Oncogene 25 2006 4505 4514 (Pubitemid 44175110)
81. C. Yang, S. Przyborski, M.J. Cooke, X. Zhang, R. Stewart, G. Anyfantis, S.P. Atkinson, G. Saretzki, L. Armstrong, and M. Lako A key role for telomerase reverse transcriptase unit in modulating human embryonic stem cell proliferation, cell cycle dynamics, and in vitro differentiation Stem Cells 26 2008 850 863
82. D.G. Farwell, K.A. Shera, J.I. Koop, G.A. Bonnet, C.P. Matthews, G.W. Reuther, M.D. Coltrera, J.K. McDougall, and A.J. Klingelhutz Genetic and epigenetic changes in human epithelial cells immortalized by telomerase Am. J. Pathol. 156 2000 1537 1547 (Pubitemid 30646693)
83. M. Serrano, G.J. Hannon, and D. Beach A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 Nature 366 1993 704 707 (Pubitemid 24036021)
84. K. Masutomi, R. Possemato, J.M. Wong, J.L. Currier, Z. Tothova, J.B. Manola, S. Ganesan, P.M. Lansdorp, K. Collins, and W.C. Hahn The telomerase reverse transcriptase regulates chromatin state and DNA damage responses Proc. Natl. Acad. Sci. U. S. A. 102 2005 8222 8227 (Pubitemid 40800070)
85. S. Jagadeesh, and P.P. Banerjee Telomerase reverse transcriptase regulates the expression of a key cell cycle regulator, cyclin D1 Biochem. Biophys. Res. Commun. 347 2006 774 780 (Pubitemid 44092650)
86. R. Czerninski, P. Amornphimoltham, V. Patel, A.A. Molinolo, and J.S. Gutkind Targeting mammalian target of rapamycin by rapamycin prevents tumor progression in an oral-specific chemical carcinogenesis model Cancer Prev. Res. (Phila) 2 2009 27 36
87. C. Wei, C.I. Amos, N. Zhang, J. Zhu, X. Wang, and M.L. Frazier Chemopreventive efficacy of rapamycin on Peutz-Jeghers syndrome in a mouse model Cancer Lett. 277 2009 149 154
88. P.A. Dennis Rapamycin for chemoprevention of upper aerodigestive tract cancers Cancer Prev. Res. (Phila) 2 2009 7 9
89. K.K. Wong Oral-specific chemical carcinogenesis in mice: an exciting model for cancer prevention and therapy Cancer Prev. Res. (Phila) 2 2009 10 13
90. C.O. da Fonseca, G. Schwartsmann, J. Fischer, J. Nagel, D. Futuro, T. Quirico-Santos, and C.R. Gattass Preliminary results from a phase I/II study of perillyl alcohol intranasal administration in adults with recurrent malignant gliomas Surg. Neurol. 70 2008 259 266 discussion 266-257
91. C.O. da Fonseca, M. Simao, I.R. Lins, R.O. Caetano, D. Futuro, and T. Quirico-Santos Efficacy of monoterpene perillyl alcohol upon survival rate of patients with recurrent glioblastoma J. Cancer Res. Clin. Oncol. 137 2011 287 293
92. S.P. Stratton, D.S. Alberts, J.G. Einspahr, P.M. Sagerman, J.A. Warneke, C. Curiel-Lewandrowski, P.B. Myrdal, K.L. Karlage, B.J. Nickoloff, C. Brooks, K. Saboda, M.L. Yozwiak, M.F. Krutzsch, C. Hu, M. Lluria-Prevatt, Z. Dong, G.T. Bowden, and P.H. Bartels A phase 2a study of topical perillyl alcohol cream for chemoprevention of skin cancer Cancer Prev. Res. 3 2010 160 169
93. S. Wada Chemoprevention of tocotrienols: the mechanism of antiproliferative effects Forum Nutr. 61 2009 204 216
94. N. Chakravarti, H. Kadara, D.J. Yoon, J.W. Shay, J.N. Myers, D. Lotan, N. Sonenberg, and R. Lotan Differential inhibition of protein translation machinery by curcumin in normal, immortalized, and malignant oral epithelial cells Cancer Prev. Res. (Phila) 3 2010 331 338
95. C.S. Beevers, L. Chen, L. Liu, Y. Luo, N.J. Webster, and S. Huang Curcumin disrupts the mammalian target of rapamycin-raptor complex Cancer Res. 69 2009 1000 1008
96. S. Mukherjee Nee Chakraborty, U. Ghosh, N.P. Bhattacharyya, R.K. Bhattacharya, S. Dey, and M. Roy Curcumin-induced apoptosis in human leukemia cell HL-60 is associated with inhibition of telomerase activity Mol. Cell. Biochem. 297 2007 31 39 (Pubitemid 46443527)
97. M. Singh, and N. Singh Molecular mechanism of curcumin induced cytotoxicity in human cervical carcinoma cells Mol. Cell. Biol. 325 2009 107 119
98. F.G. Perabo, E.C. Von Low, J. Ellinger, A. von Rucker, S.C. Muller, and P.J. Bastian Soy isoflavone genistein in prevention and treatment of prostate cancer Prostate Cancer Prostatic. Dis. 11 2008 6 12 (Pubitemid 351250324)
99. Y. Yuan, and L.R. Ferguson Nutrigenetics and prostate cancer: 2011 and beyond J. Nutrigenet. Nutrigenomics 4 2011 121 136